To Top
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.

Alagille Syndrome Alliance


PO Box 22
Collierville, TN 38017 USA



Email Address

[email protected]


The Alagille Syndrome Alliance (ALGSA) is a non-profit advocacy and support organization for people affected by Alagille syndrome (ALGS), a rare genetic disorder. Established in 1993, the ALGSA is dedicated to providing support to individuals with this disorder, their family members, and healthcare professionals who care for them. The ALGSA advocates for continuing medical research into the cause, prevention, and treatment of ALGS, offers advice through specialists on its Medical Advisory Board, and funds research grants. The ALGSA serves as a central location for resources related to the diagnosis and treatment of this rare disorder.

Please Note

The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.

NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.